VINC insider transaction filings
Vincerx Pharma, Inc. — 13 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-08-14. Screen VINC transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for VINC between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — Vincerx Pharma, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-08-14 | 4 | Seelenberger Alexander A. — Chief Financial Officer | Disposition to issuer (D): 200,000 (derivative) · Grant/award (A): 200,000 (derivative) · Disposition to issuer (D): 55,250 (derivative) · Grant/award (A): 55,250 (derivative) · Disposition to issuer (D): 58,000 (derivative) · Grant/award (A): 58,000 (derivative) · +8 more | EDGAR |
| 2024-08-14 | 4 | Izumi Raquel E. — See Remarks, Director | Disposition to issuer (D): 76,500 (derivative) · Grant/award (A): 76,500 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Grant/award (A): 60,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Grant/award (A): 60,000 (derivative) · +6 more | EDGAR |
| 2024-08-14 | 4 | Hamdy Ahmed MD — Chief Executive Officer, Director | Disposition to issuer (D): 127,500 (derivative) · Grant/award (A): 127,500 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Grant/award (A): 60,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Grant/award (A): 60,000 (derivative) · +6 more | EDGAR |
| 2024-08-14 | 4 | THOMAS TOM C — See Remarks | Disposition to issuer (D): 175,000 (derivative) · Grant/award (A): 175,000 (derivative) · Disposition to issuer (D): 55,250 (derivative) · Grant/award (A): 55,250 (derivative) · Disposition to issuer (D): 58,000 (derivative) · Grant/award (A): 58,000 (derivative) · +8 more | EDGAR |
| 2024-05-29 | 4 | Seelenberger Alexander A. — Chief Financial Officer | Grant/award (A): 31,250 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Izumi Raquel E. — See Remarks, Director | Grant/award (A): 41,250 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Hamdy Ahmed MD — Chief Executive Officer, Director | Grant/award (A): 53,254 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | THOMAS TOM C — See Remarks | Grant/award (A): 31,250 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Salva Francisco D. — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Lee John H. — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Stevens Ruth E. — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Bushnell Laura I. — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Druker Brian — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Vincerx Pharma, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-07-07 | 8-K | 1.02 — Termination of a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-17 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-11 | 8-K | 1.02 — Termination of a Material Definitive Agreement 8.01 — Other Events | EDGAR |
| 2025-03-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-28 | 8-K | 1.02 — Termination of a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-18 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-02-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VINC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →